Medplus Health Services Limited — Important, 19-11-2024: General Updates

Optival Health Solutions, a subsidiary of MedPlus Health Services, has received suspension orders for five drug licenses at various Pune locations. The suspensions are set to last fifteen days for some stores and for twelve to ten days for others. These actions stem from violations under the Drugs and Cosmetics Act, 1940. The potential revenue loss is estimated at approximately ₹11.94 cr, ₹10.36 cr, ₹5.70 cr, ₹8.65 cr, and ₹9.12 cr across the affected locations. This development may impact the financial performance of MedPlus, warranting close attention from investors.